NASDAQ:ANGO AngioDynamics Q1 2027 Earnings Report $15.38 -0.22 (-1.41%) Closing price 04:00 PM EasternExtended Trading$15.31 -0.07 (-0.46%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast AngioDynamics EPS ResultsActual EPSN/AConsensus EPS -$0.11Beat/MissN/AOne Year Ago EPSN/AAngioDynamics Revenue ResultsActual RevenueN/AExpected Revenue$80.51 millionBeat/MissN/AYoY Revenue GrowthN/AAngioDynamics Announcement DetailsQuarterQ1 2027Date10/8/2026TimeBefore Market OpensConference Call DateThursday, October 8, 2026Conference Call Time8:00AM ETConference Call ResourcesEarnings HistoryCompany Profile AngioDynamics Earnings HeadlinesAngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026September 28 at 5:00 PM | businesswire.comAngioDynamics (ANGO) Expected to Post Quarterly Earnings on ThursdaySeptember 24, 2026 | americanbankingnews.comThe $7 trillion infrastructure buildout in progressMcKinsey projects nearly $7 trillion could pour into a new global infrastructure buildout by 2030 - larger than the annual economies of Japan, Germany, and India combined. Weiss Ratings' Chief Venture Strategist Chris Graebe says surging demand for a resource he calls Computium is the trigger behind this massive spending wave, and he's identified the lesser-known companies positioned to benefit. Graebe points to October 12 as a potential turning point for this opportunity.September 30 at 1:00 AM | Weiss Ratings (Ad)AngioDynamics, Inc. (NASDAQ:ANGO) Given Average Recommendation of "Hold" by BrokeragesSeptember 20, 2026 | americanbankingnews.comAngioDynamics, Inc. (ANGO) Presents at Canaccord Genuity's 46th Annual Growth Conference - SlideshowAugust 11, 2026 | seekingalpha.comTop AngioDynamics Executive Makes Bold Move With Major Stock SaleJuly 31, 2026 | tipranks.comSee More AngioDynamics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like AngioDynamics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AngioDynamics and other key companies, straight to your email. Email Address About AngioDynamicsAngioDynamics (NASDAQ:ANGO) (NASDAQ: ANGO) is a medical technology company that develops and manufactures minimally invasive devices used in vascular, oncology, and surgical procedures. Its products are designed to help physicians diagnose and treat vascular disease, remove or manage blood clots, and deliver targeted therapies for certain cancers and other conditions. The company’s product portfolio includes the Auryon Atherectomy System for treating peripheral arterial disease, the AngioVac System for the removal of unwanted intravascular material, and the NanoKnife System, which uses irreversible electroporation to ablate soft-tissue tumors. AngioDynamics also offers devices for vascular access and other interventional procedures, including systems intended to support catheter placement and reduce complications. Founded in 1988 and headquartered in Latham, New York, AngioDynamics sells its products through a combination of direct sales and distributors in the United States and international markets. The company serves hospitals, physicians, and other healthcare providers, with an emphasis on technologies that can be used in less invasive alternatives to traditional surgery.View AngioDynamics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?CarMax Just Gave Investors a Better Reason to Believe in the TurnaroundArhaus Has New Momentum—Could Other Furniture Stocks Be Next?Bernstein Downgrades 3 Cybersecurity Stocks: How Concerned Should Investors Be?Brewing Trouble? Starbucks Spills the Beans on 250 Store ClosuresMarketBeat Week in Review – 09/21 - 09/25Analyst Rating Boosts May Signal More Upside for These 3 Stocks Upcoming Earnings NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
